Celltrion Healthcare Decides to Acquire Additional Treasury Shares Worth 25 Billion KRW

"Will Continue Responsible Management to Enhance Shareholder Value"

Celltrion Healthcare has decided to purchase additional treasury shares to enhance shareholder value and stabilize its stock price.

Celltrion Healthcare announced on the 8th that it plans to acquire a total of 398,000 treasury shares through on-market purchases over three months from the 9th to June 8. The scale of the treasury share acquisition is approximately 25 billion KRW.

Additionally, Celltrion Healthcare disclosed that it has completed the acquisition of 437,000 treasury shares decided last month. As a result, the total number of treasury shares held by Celltrion Healthcare has increased to 3,569,331 shares. Including the newly announced additional acquisition, the total treasury shares acquired this year amount to 835,000 shares.

Treasury share acquisitions can help boost stock prices by reducing the number of shares circulating in the market. There is also a perspective that treasury share purchases demonstrate a company's cash mobilization capability.

A representative of Celltrion Healthcare stated, "We determined that the stock price is still undervalued compared to the company's intrinsic value, which led to the treasury share purchase last month and the decision to acquire additional shares this time. We plan to strengthen the company's business competitiveness through expanding global direct sales regions and diversifying the product portfolio, and we will continue responsible management to enhance corporate and shareholder value."